Business
Website Update
Website Update.
About this update from Valirx Plc
[{"type":"text","content":"\n \n\n\n\n\n\nRNS Number : 8988B ValiRx PLC 25 February 2011 \n \n\n25 February 2011\nValiRx Plc\n(\"ValiRx\" or the \"Company\")\nWebsite Update\n \nThe Company announces that it has today uploaded a document on its AIM Rule 26 website (www.valirx.com) responding to frequently asked questions received from shareholders in relation to its recent announcements on the launch of its chlamydia self-check health screening product (14 February 2011) and issue of equity (16 February 2011). \n\n \n \nFor more information, please contact:\n \n\n\n\n\nValiRx plc \n\n\nwww.ValiRx.com\n\n\n\n\nDr Satu Vainikka\n\n\nTel: +44 (0) 20 3008 4416\n\n\n\n\n\n\n\n\n\n\n\n\nCairn Financial Advisers LLP \n\n\n\n\n\n\n\nNominated Adviser\n\n\nTel: +44 (0) 20 7148 7900\n\n\n\n\nLiam Murray / Avi Robinson\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nHybridan LLP\n\n\n\n\n\n\n\nBroker\n\n\nTel: +44 (0) 20 7947 4350\n\n\n\n\nClaire Noyce\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPeckwater PR\n\n\nTel: +44 (0)7879 458 364\n\n\n\n\nTarquin Edwards\n\n\[email protected] \n\n\n\n\n \n \nNotes for Editors\n \nValiRx Plc\nValiRx Plc is a biopharmaceutical company developing novel technologies and products in oncology therapeutics and diagnostics. The product focus is in the epigenomic analysis and treatment of cancer, but the technologies can be applied to other fields as well, such as neurology and inflammatory diseases.\n \nThe Company listed on AIM in October 2006 and is creating a portfolio of innovative products through investment in specific development projects. It actively manages projects within this portfolio as a trading company and is not an investment vehicle. The ValiRx business model spreads the risks of life science technology developments by minimising financial exposure and running a set of projects to defined commercial endpoints. This maximises returns to shareholders by adding value at the earlier stages where value increases per investment unit are the greatest. \n \nThe Company operates through the following divisional companies:\n· ValiMedix is the sales and distribution division of ValiRx\n· ValiPharma is the therapeutics division with two embedded technologies primarily directed at the treatment of cancers. Of particular ...